资讯

The American Journal of Managed Care46 分钟
Patients With Multiple Types of Mismatch Repair-Deficient Tumors Avoid Surgery With Dostarlimab
Dostarlimab effectively eliminates the need for surgery in patients with advanced mismatch repair-deficient (dMMR) tumors, ...